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Introduction
Verticillium wilt is an important disease responsible for
dramatic yield losses in many crops all over the
world (Pegg and Brady 2002). Verticillium dahliae and
Verticillium longisporum produce melanized resting
structures, microsclerotia, which can survive for more
than a decade in soil. Microsclerotia are stimulated to
germinate by root exudates. The infectious hyphae
that emerge from the microsclerotia penetrate the roots
of the host plant (Schnathorst 1981). Because the
microsclerotia are the most important structures of the
pathogen for survival and in causing initial infections,
the microsclerotia are regarded as one of the direct
targets of biological control of Verticillium (Tjamos
2000).
In the past, studies on biological control of Verticillium
microsclerotia have typically focused on the use of the
fungus Talaromyces flavus. This fungal antagonist kills
individual Verticillium microsclerotia in vitro, because of
the production of glucose oxidase that converts glucose
to hydrogen peroxide (Fravel et al. 1987; Kim et al. 1988;
Fahima et al. 1992). In recent years, bacterial antagonists,
e.g. Pseudomonas spp., have also been identified as poten-
tial biological control agents for Verticillium wilt (e.g.
Leben et al. 1987; Berg et al. 2001; Mercado-Blanco et al.
2004). These previous studies have specifically targeted
the suppression of the hyphal growth of Verticillium.
However, to our knowledge, no research has ever looked
at the direct effect of these bacterial antagonists on the
viability of individual Verticillium microsclerotia in vitro.
As mentioned, a better control of microsclerotia is
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Abstract
Aims: To examine the effect of previously described bacterial antagonists on
the viability of Verticillium microsclerotia in vitro and to elucidate the possible
modes of action of bacterial strains in the suppression of Verticillium micro-
sclerotia viability.
Methods and Results: A microplate assay was developed to test the suppressive
effect of well-defined Pseudomonas spp. on the viability of Verticillium micro-
sclerotia in vitro. Experiments using phenazine- and biosurfactant-deficient
mutants indicated that biosurfactants and phenazine-1-carboxylic acid play a
role in the suppression of microsclerotia viability by Pseudomonas spp. In addi-
tion, microsclerotia colonization tests revealed that Pseudomonas spp. are able
to colonize the surface of the microsclerotia, but not the inner matrix. Growth
response curves showed that the population levels of Pseudomonas spp.
increased when they were in the vicinity of Verticillium microsclerotia, indica-
ting that Pseudomonas spp. may utilize nutrients from the microsclerotia for
their growth.
Conclusions: Pseudomonas spp. seem to be good candidates for Verticilllium
microsclerotia biocontrol. Biosurfactant production is one of the main mecha-
nisms involved in their mode of action.
Significance and Impact of the Study: This line of work may contribute to a
better understanding of biological control agents and their working mecha-
nisms.
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important, as they are the key structures responsible for
survival and infection by Verticillium.
A common mechanism underlying the direct antagon-
istic activity towards soil pathogens by Pseudomonas is
the production of antifungal compounds. These antifun-
gal compounds include the secretion of antibiotics and
siderophores (Dwivedi and Johri 2003), biosurfactants (de
Souza et al. 2003; Raaijmakers et al. 2006) and lytic
enzymes (Velazhahan et al. 1999).
In this article, we investigate the role of phenazines and
biosurfactants in the Pseudomonas-mediated reduction of
Verticillium microsclerotia viability. Phenazines are a large
family of heterocyclic nitrogen-containing pigments with
broad-spectrum antibiotic activity. It is assumed that they
diffuse across or insert into the membrane of plant path-
ogens and act as a reducing agent, resulting in the genera-
tion of toxic superoxide radicals and hydrogen peroxide
(Chin-A-Woeng et al. 2003). Some of the best-known
phenazines involved in biological control are phenazine-
1-carboxylic acid (PCA), phenazine-1-carboxamide
(PCN) and pyocyanin (Chin-A-Woeng et al. 2003). For
example, Pseudomonas chlororaphis PCL1391 produces
PCN, which is responsible for the biological control of
Fusarium oxysporum (Chin-A-Woeng et al. 1998, 2001).
Pseudomonas aeruginosa PNA1 produces PCA and PCN,
which are involved in the control of Pythium spp. (Anja-
iah et al. 1998; Tambong and Ho¨fte 2001). Ps. fluorescens
is able to suppress the take-all disease on wheat by the
production of PCA (Thomashow and Weller 1988).
Biosurfactants are surface-active compounds produced by
a variety of microorganisms. The mode of action of bio-
surfactants in biological control involves the formation of
channels in the cell wall and perturbations of the cell
surface of the pathogen (Raaijmakers et al. 2006). The
best-known biosurfactants in biological control are cyclic
lipopeptides (Raaijmakers et al. 2006) and rhamnolipids
(Stanghellini and Miller 1997). For example, Pseudomonas
CMR12a produces a cyclic lipopeptide responsible for
the control of Pythium and Phytophtora spp. (Perneel
2006), while Ps. aeruginosa PNA1 produces rhamnolipids
(Perneel 2006).
Apart from the production of antifungal compounds, a
second important mechanism by which bacterial antago-
nists may control soil pathogens, is that they may com-
pete with the pathogen for nutrients, as both the
pathogen and the bacterium can have similar carbon
source nutrient utilization profiles (Ellis et al. 1999). For
example, Jana et al. (2000) found that loss of nutrients
from the sclerotia of Macrophomina phaseolina incubated
with isolates of Ps. fluorescens was directly correlated with
germination suppression.
A first aim of the present study was to examine the
effect of previously described bacterial antagonists on the
viability of Verticillium microsclerotia in vitro. More spe-
cifically, four Pseudomonas spp., including Ps. chlororaphis
PCL1391, Pseudomonas CMR12a, Ps. aeruginosa PNA1
and 7NSK2; were tested for their ability to suppress Verti-
cillium microsclerotia viability. These bacterial strains
have previously shown biological control activity towards
several soil pathogens (e.g. Buysens et al. 1996; Anjaiah
et al. 1998; Chin-A-Woeng et al. 1998; Tambong and
Ho¨fte 2001).
The second aim of the present study was to elucidate
the possible modes of action of bacterial strains in the
suppression of Verticillium microsclerotia viability. Two
hypotheses were investigated. Initially it was investigated
whether the secretion of phenazines and biosurfactants
might be involved in the biological control ability of the
bacterial strains. This strategy was inspired by previous
findings, demonstrating that phenazines and ⁄or biosurfac-
tants are involved in the biological control activity of
other plant pathogens by these bacterial strains (Anjaiah
et al. 1998; Chin-A-Woeng et al. 1998; Tambong and
Ho¨fte 2001). Second, we investigated whether the bacter-
ial antagonists might colonize Verticillium microsclerotia
and utilize nutrients from Verticillium microsclerotia for
their growth, as described above.
Material and methods
Bacterial strains and culture conditions
The bacterial strains and plasmids used in this study are
listed in Table 1. All the bacteria listed in Table 1 have
been previously described, except for Pseudomonas
CMR12a-PhzH (see below) and Ps. aeruginosa PNA1-
PhzH (see below).
King’s medium B (KB) (King et al. 1954) was used
routinely to culture Pseudomonas spp. strains at 37C
(Pseudomonas CMR12a and Ps. chlororaphis PCL1391) or
at 37C (Ps. aeruginosa PNA1 and 7NSK2). Escherichia
coli strains were grown in Luria-Bertani medium at 37C
(Sambrook et al. 1989). Gentamycin, tetracyclin and
kanamycin antibiotics were used at the following concen-
trations; for E. coli 25 lg ml)1 and for Pseudomonas spp.
100 lg ml)1.
Construction of Pseudomonas phzH mutants
Plasmid preparation, ligation, cloning and transforma-
tion were performed according to standard methods
(Sambrook et al. 1989). Taq DNA Polymerase and
Q-solution were purchased from Qiagen (Venlo, the
Netherlands) and polymerase chain reaction (PCR) was
carried out as recommended by the manufacturer. The
primers used are listed in Table 1.
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CMR12a-PhzH is a phzH mutant of CMR12a, gener-
ated by the use of the allelic exchange vector pJK100.
Plasmid pJK100 (3854 bp) is a suicide vector carrying a
tetracyclin resistance element, an R6 Kc origin of replica-
tion, the RP4 origin of transfer and MCS-loxP-KmR-
loxP-MCS (Marx and Lidstrom 2002; Denef et al. 2006).
Plasmids with the R6 Kc origin of replication were propa-
gated in a genetically modified E. coli strain carrying the
pir gene (WM3064; Denef et al. 2006). The regions imme-
diately flanking the phzH gene (592 bp phzH-upstream
and 539 bp phzH-downstream) were amplified by PCR
and inserted into pJK100 (intermediate and final con-
structs in Table 1) as described previously (Marx and
Lidstrom 2002). A DphzH::kan mutant of CMR12a was
generated by introducing pJK100-PhzHUp-PhzHDown by
triparental conjugation from E. coli WM3064 with the aid
of E. coli HB101 (pRK2013) (Boyer and Roulland-Dossoix
1969). Kanamycin-resistant transconjugants were screened
for tetracyclin sensitivity, to confirm the double-crossover
event.
PNA1-PhzH is a phzH mutant of PNA1, generated by
the insertion of the vector pKnockout-G, a mobilizable
suicide vector (6 kb) with a gentamycin resistance cas-
sette (Windgassen et al. 2000). An internal fragment
(921 bp) of the phzH gene of Ps. aeruginosa PNA1 was
amplified by PCR with primers designed in frame with
the phzH gene (PNA1PhzH-F ⁄R). The PCR fragment
was cloned into pKnockout-G, resulting in pKOG-phzH
(Table 1). This plasmid was used as a suicide vector in a
Ps. aeruginosa PNA1 background to obtain a phzH
mutant of strain PNA1 by single homologous recombi-
nation.
CMR12a-PhzH and PNA1-PhzH transconjugants were
screened for the loss of PCN-production by means of
thin-layer chromatography (TLC). The performance of
the constructed phzH mutants when compared with the
wild type has been checked thoroughly. More specifically,
the production of biosurfactants was assessed using the
drop collapse technique as described by Jain et al. (1991).
HCN was detected by cyanide-indicator paper according
to Bakker and Schippers (1987). Protease activity was
detected as clearing zones on LB-medium amended with
2% skim milk powder (Sacherer et al. 1994). Swarming
phenotype and fluorescence were checked on KB agar
plates (Kinscherf and Willis 1999).
Inoculum preparation
Each strain and its derivatives were grown on a specific
medium (Table 1), as previous research showed that these
media stimulate the production of the secondary metabo-
lites under study. More specifically, Pseudomonas P Agar
(PPA) is a phosphate-limiting medium and phosphate
limitation stimulates the production of phenazines by
Pseudomonas spp. (Frank and Demoss 1959). Further-
more, we showed that KB medium seems to stimulate
biosurfactants production by Pseudomonas spp. (data not
shown). For inoculum preparation, all strains were grown
at 28C for 24 h on the respective medium, except for
the Ps. aeruginosa strains, which were grown at 37C.
After incubation, the bacteria were scraped from the
medium and suspended in sterile physiological solution.
Bacterial concentration in the suspension was determined
spectrophotometrically by measuring absorbance at
620 nm.
Verticillium isolate and microsclerotia preparation
The cauliflower isolate O1 of V. longisporum was used
throughout this study. This isolate was randomly chosen
out of five European Verticillium strains from cauliflower
previously described (Debode et al. 2005). The isolate was
routinely grown on potato dextrose agar plates at 24C
and conserved in a MicrobankTM (Pro-lab Diagnostics,
ON, Canada) at )80C. Dry, individual microsclerotia
were produced as described by Hawke and Lazarovits
(1994). During this procedure, the microsclerotia are
grown in semisolid medium, harvested by wet sieving (to
remove medium, spores and mycelium), mixed with sand
(to dry without clumping) and sorted into size classes by
dry sieving. Subsequently, microsclerotia with a size of
75 lm or more were retained and suspended in sterile
water containing 0Æ08% water agar to obtain a homogen-
eous suspension. To determine the concentration, the
number of microsclerotia in the suspension was deter-
mined in small subsamples (15 ll) using a dissecting
microscope.
Microsclerotia germination assay
To test the effect of bacterial antagonists on the viability
of microsclerotia, a microplate assay was developed
(Fig. 1). Nylon mesh filters (pore size 41 lm, diameter
25 mm, Millipore, Billerica, MA, USA) were placed in
wells of a 96-well microplate. Subsequently, 20 ll of the
microsclerotia preparation was embedded in the filters,
resulting in about 50 microsclerotia per filter. In addition,
180 ll of the bacterial suspension was added to the wells
(2 · 107 and 2 · 109 CFU ml)1). Sterile physiological
solution (180 ll) served as control treatment. A total vol-
ume of 200 ll per well was used, because volumes
exceeding 200 ll per well may cause limited oxygen diffu-
sion (Broekaert et al. 1990). The microplate was incuba-
ted for 2 days at 24C. After incubation, the filters were
retrieved from the microplate and placed on sterile filter
paper under sterile conditions. After 15 minutes, the fil-
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ters were dry and placed on soil-pectate-tergitol agar
(SPTA) plates containing 50 mg l)1 each of chloram-
phenicol, tetracyclin and streptomycin sulfate (Hawke
and Lazarovits 1994). Ten days after incubation of the
plates, the filters were examined under a dissecting micro-
scope both for germination percentage and formation of
secondary microsclerotia. There were five replications per
treatment and each experiment was repeated once.
In a first step, the four wild–type bacteria listed in
Table 1 were screened for their ability to suppress the
viability of Verticillium microsclerotia in vitro. In a sec-
ond step, several mutants deficient in phenazines or bio-
surfactants production were tested to elucidate the
involvement of phenazines and biosurfactants in the
Pseudomonas-mediated reduction of Verticillium micro-
sclerotia.
Microsclerotia colonization assay
To determine the ability of Ps. chlororaphis PCL1391,
Pseudomonas CMR12a, Ps. aeruginosa PNA1 and 7NSK2
to colonize the surface and the inner matrix of Verticil-
lium microsclerotia, 20 ll of a microsclerotia suspension
containing about 200 microsclerotia was added to each
well of a microplate. In addition, 180 ll of a bacterial
suspension was added in a concentration of 2 ·
107 CFU ml)1. Sterile physiological solution (180 ll)
served as control treatment. The microsclerotia were
incubated for 2 days at 25C. To determine the surface
and inner colonization after incubation, the microsclerotia
were washed two times with sterile distilled water and
ground in 200 ll physiological solution using an auto-
claved pestle. To determine the inner matrix colonization
alone, the microsclerotia were surface-disinfested in 0Æ5%
NaOCl for 2 min, washed two times in sterile distilled
water and ground in 200 ll physiological solution using
an autoclaved pestle. This disinfection procedure should
be robust enough to kill the bacteria on the surface of the
microsclerotia (Melouk 1992). The bacteria in the ground
microsclerotia solutions were enumerated by serial dilu-
tions. Each experiment consisted of two replicates per
treatment and each experiment was repeated once.
Growth response of bacteria in vicinity of Verticillium
microsclerotia
To determine the growth response of Ps. chlororaphis
PCL1391, Pseudomonas CMR12a, Ps. aeruginosa PNA1
and 7NSK2 in vicinity of Verticillium microsclerotia,
20 ll containing a concentration rage of 0–500 microscle-
rotia were put in each well of a microplate. Subsequently,
180 ll of a bacterial suspension containing 2 · 101,
2 · 103, 2 · 105, 2 · 107 and 2 · 109 CFU ml)1 was
added to each well. Sterile physiological solution (180 ll)
served as control treatment. The microplate was incuba-
ted for 2 days. The concentration of bacteria after incuba-
tion was determined by serial dilutions. Each experiment
consisted of two replicates per treatment and each experi-
ment was repeated once.
Data analysis
The percentage of Verticillium microsclerotia germination
was expressed relative to the control. Univariate repeated
measurements were used and multiple comparisons of
the means were performed using post hoc Tukey test
(P = 0Æ05).
Results
Effect of wild-type bacteria on the viability of
Verticillium microsclerotia
The effect of the four wild-type bacteria listed in Table 1
on the viability of Verticillium microsclerotia was evalu-
ated with regard to (i) microsclerotia germination and
(ii) formation of secondary microsclerotia. Figure 2
shows the effect of the wild-type bacteria on microscle-
rotia germination. When 2 · 107 CFU ml)1 bacteria
were added in the microtiter assay, only Ps. chlororaphis
PCL1391 was effective in reducing microsclerotia germi-
nation. When 2 · 109 CFU ml)1 bacteria were added, all
bacteria were able to suppress the germination of the
Verticillium microsclerotia. In addition, only a few of
the Pseudomonas-treated microsclerotia formed secondary
microsclerotia, whereas all colonies arising from the con-
trol treatment formed secondary microsclerotia (data not
shown).
Figure 1 Microplate assay: nylon mesh filters placed in wells of a
96-well microplate.
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Characterization of the phzH mutants
TLC plates showed that PNA1-PhzH and CMR12a-PhzH
are impaired in PCN production and produce PCA
instead. In addition, both mutants were not altered in bio-
surfactants production, HCN production, protease activ-
ity, swarming phenotype, fluorescence ability and viability.
Involvement of phenazines and biosurfactants
Pseudomonas chlororaphis PCL1391 has been shown to be
the best candidate for Verticillium microsclerotia suppres-
sion (see Fig. 2). The involvement of the phenazine PCN
in Ps. chlororaphis PCL1391-mediated reduction of Verti-
cillium microsclerotia viability was investigated by testing
two mutants of PCL1391: PCL1121 and PCL1119. A
seven-gene operon (phzABCDEFG) is responsible for the
synthesis of phenazine-1-carboxylic acid (PCA), and phzH
encodes for an asparagine synthetase like enzyme, which
is responsible for the conversion of PCA to phenazine-1-
carboxamide (PCN). A phzB mutant (such as PCL1119)
is phenazine-deficient and a phzH mutant (such as
PCL1121) produces PCA instead of PCN (Chin-A-Woeng
et al. 1998, 2001; Mavrodi et al. 2001). PCL1119 was as
effective in the inhibition of microsclerotia germination
as the wild type, whereas PCL1121 was more effective
when compared with the wild type (Fig. 3a). In addition,
PCL1121 was also more effective in the suppression of
the formation of secondary microsclerotia when com-
pared with the wild type. None of the germinated micro-
sclerotia treated with PCL1121 were able to form
secondary microsclerotia, whereas all the germinated
microsclerotia in the control treatment formed secondary
microsclerotia. A few of the germinated microsclerotia
treated with PCL1391 and PCL1119 were able to form
secondary microsclerotia (Fig. 3b).
The role of the phenazine pyocyanin produced by Ps.
aeruginosa 7NSK2 was investigated by testing the effect of
Ps. aeruginosa 7NSK2-PhzM on the viability of Verticil-
lium microsclerotia. The pyocyanin-negative mutant
7NSK2-PhzM was constructed by gene replacement of the
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Figure 3 (a) Percentage of germinated Verticillium microsclerotia
exposed to 2 · 107 CFU ml)1 (open bars) and 2 · 109 CFU ml)1 (solid
bars) of the wild-type bacterium, Pseudomonas chlororaphis PCL1391
and his mutants PCL1121 and PCL1119. Bars indicated with the same
letter are not significantly different after data analysis with a post hoc
Tukey test (P < 0Æ05). PCN, phenazine-1-carboxamide; PCA, phena-
zine-1-carboxylic acid. (b). Effect of 2 · 109 CFU ml)1 of Ps. chloror-
aphis PCL1391, PCL1119 and PCL1121 on the formation of
secondary microsclerotia when compared with the control treatment.
(i) PCL1391, wild type (ii) PCL1119, PCA and PCN deficient mutant
(iii) PCL1121, PCA+ mutant (iv) control treatment.
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Figure 2 Percentage of germinated Verticillium microsclerotia
exposed to 2 · 107 CFU ml)1 (open bars) and 2 · 109 CFU ml)1 (solid
bars) of four different wild-type Pseudomonas spp. Bars indicated with
the same letter are not significantly different after data analysis with a
post hoc Tukey test (P < 0Æ05).
Biological control of Verticillium J. Debode et al.
6 Journal compilation ª 2007 The Society for Applied Microbiology, Journal of Applied Microbiology
ª 2007 The Authors
phzM gene (De Vleesschauwer et al. 2006), encoding an
O-methyl transferase, which is necessary for the conver-
sion of PCA to the pyocyanin precursor 5-methylphena-
zine-1-carboxylic acid betaine (Mavrodi et al. 2001). As
can be seen in Fig. 4, Ps. aeruginosa 7NSK2-PhzM was
more effective in inhibition of the Verticillium microscle-
rotia germination when compared with the wild type
(Fig. 4). In addition, none of the germinated microsclerotia
treated with 7NSK2-PhzM were able to form secondary
microsclerotia, whereas a few microsclerotia treated with
the wild type were able to form secondary microsclerotia.
All the germinated microsclerotia in the control treatment
were able to form secondary microsclerotia (data not
shown).
To determine the involvement of biosurfactants (rham-
nolipids) and phenazines (PCA and PCN) produced by
Ps. aeruginosa PNA1 in the reduction of Verticillium
microsclerotia viability, the effect of two mutants, PNA1-
PhzH and PNA1-Rhl, on the viability of Verticillium
microsclerotia was compared with the wild type. Similar
to PCL1121, PNA1-PhzH is impaired in PCN production
because of a phzH mutation and produces PCA (TLC –
data not shown) and PNA1-Rhl is impaired in biosurfac-
tants (rhamnolipid) production (Perneel 2006). PNA1-
PhzH was as effective as the wild-type treatment, whereas
PNA1-Rhl was no longer able to reduce microsclerotia
germination (Fig. 5a). All the germinated microsclerotia
in the control treatment were able to form secondary
microsclerotia. None of the germinated microsclerotia
treated with PNA1 or PNA1-PhzH were able to form sec-
ondary microsclerotia. For the microsclerotia treated with
the biosurfactants mutant, PNA1-Rhl, a few of the germi-
nated microsclerotia formed secondary microsclerotia,
indicating that this mutant had an inhibitory effect on
the viability of Verticillium microsclerotia (Fig. 5b).
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Figure 4 Percentage of germinated Verticillium microsclerotia
exposed to 2 · 107 CFU ml)1 (open bars) and 2 · 109 CFU ml)1 (solid
bars) of the wild-type bacterium, Pseudomonas aeruginosa 7NSK2
and its mutant 7NSK-PhzM. Bars indicated with the same letter are
not significantly different after data analysis with a post hoc Tukey
test (P < 0Æ05). PCA, phenazine-1-carboxylic acid.
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Figure 5 (a) Percentage of germinated Verticillium microsclerotia
exposed to 2 · 107 CFU ml)1 (open bars) and 2 · 109 CFU ml)1 (solid
bars) of the wild-type bacterium, Pseudomonas aeruginosa PNA1
and its mutants PNA1-PhzH and PNA1-Rhl. Bars indicated with the
same letter are not significantly different after data analysis with a
post hoc Tukey test (P < 0Æ05). PCN, phenazine-1-carboxamide; PCA,
phenazine-1-carboxylic acid; BS, biosurfactants. (b) Effect of
2 · 109 CFU ml)1 of Ps. aeruginosa PNA1, PNA1-PhzH and PNA1-Rhl
on the formation of secondary microsclerotia when compared with
the control treatment. (i) PNA1, wild type (ii) PNA1-PhzH, PCA+
mutant (iii) PNA1-Rhl, biosurfactant deficient mutant (iv) control treat-
ment.
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The effect of CMR12a-7Æ97 and CMR12a-PhzH was
tested on the viability of Verticillium microsclerotia when
compared with the effect of the wild type. CMR12a-7Æ97
is impaired in the panC gene, coding for pantoate-b-
alanine ligase and responsible for the production of pant-
othenate, a precursor of an important cofactor of cyclic
lipopeptide synthetases (Perneel 2006). As such, CMR12a-
7Æ97 is impaired in biosurfactant production. Many trans-
conjugants had to be screened to find a phzH mutant in
CMR12a, as the frequency of double homologous recom-
bination with pJK100-phzHUp-phzHDown is probably
very low. Whereas CMR12a produces PCA and PCN, its
phzH mutant CMR12a-PhzH accumulates PCA (TLC –
data not shown). CMR12a-7Æ97 was less effective when
compared with the wild type, but still had an inhibitory
effect on the microsclerotia germination. The effect of
CMR12a-PhzH on the viability of Verticillium microscle-
rotia was not significantly different from the wild-type
treatment (Fig. 6). A few of the germinated microsclerotia
treated with CMR12a-7Æ97 were able to form secondary
microsclerotia, whereas none of the germinated microscle-
rotia treated with CMR12a and CMR12a-PhzH were able
to form secondary microsclerotia. All of the germinated
microsclerotia in the control treatment were able to form
secondary microsclerotia (data not shown).
Microsclerotia colonization assay
To determine the ability of the bacteria to colonize the
surface and the inner matrix of the microsclerotia,
microsclerotia were treated with 2 · 107 CFU ml)1 bac-
teria and incubated for 2 days. After incubation, the
microsclerotia were washed to determine the surface col-
onization and disinfected to determine the inner matrix
colonization.
The bacterial population on the surface of the microscle-
rotia was 3Æ9 (±3Æ2) · 104 CFU ml)1 for Ps. chlororaphis
PCL1391, 4Æ1 (±1Æ9) · 104 CFU ml)1 for Ps. aeruginosa
7NSK2, 5Æ2 (±1Æ3) · 104 CFU ml)1 for Ps. aeruginosa
PNA1 and 4Æ8(±2Æ8) · 104 CFU ml)1 for Pseudomonas
CMR12a (values between brackets indicate standard devia-
tions). There was no significant difference in surface colon-
izing ability between the tested Pseudomonas strains.
When we looked at the inner matrix colonization ability
of the strains, no bacteria could be detected in the disin-
fected microsclerotia (detection limit was 100 CFU ml)1),
indicating that the tested Pseudomonas strains are not able
to colonize the inner matrix of the microsclerotia.
Growth response of bacteria in vicinity of Verticillium
microsclerotia
To determine the growth response of Ps. chlororaphis
PCL1391 and Ps. aeruginosa 7NSK2 bacteria in the
vicinity of Verticillium microsclerotia, various concentra-
tions of bacteria were incubated for 2 days in a solution
containing increasing amounts of Verticillium microscle-
rotia per 200 ll. When Ps. chlororaphis PCL1391 and
Ps. aeruginosa 7NSK2 were incubated with 0 or 5 micro-
sclerotia per 200 ll, populations after 2 days of incuba-
tion were similar to the initial bacterial population
added. When Ps. chlororaphis PCL1391 and Ps. aerugi-
nosa 7NSK2 were incubated at low concentrations
(2 · 101, 2 · 103 and 2 · 105 CFU ml)1) with 25 or
more microsclerotia per 200 ll, a clear increase in the
population was observed. When a high bacterial concen-
tration (2 · 107 and 2 · 109 CFU ml)1) was initially
added, there was no additional growth after 2 days of
incubation (Fig. 7a,b).
Similar results were obtained for Ps. aeruginosa PNA1
and Pseudomonas CMR12a (data not shown).
Discussion
Effect of wild-type bacteria on the viability of
Verticillium microsclerotia
Contrary to the common assumption that melanized
structures are resistant to microbial attack (Bell and
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Figure 6 Percentage of germinated Verticillium microsclerotia
exposed to 2 · 107 CFU ml)1 (open bars) and 2 · 109 CFU ml)1 (solid
bars) of the wild-type bacterium, Pseudomonas CMR12a and its
mutants CMR12a-PhzH and CMR12a-7Æ97. Bars indicated with the
same letter are not significantly different after data analysis with a
post hoc Tukey test (P < 0Æ05). PCN, phenazine-1-carboxamide; PCA,
phenazine-1-carboxylic acid; BS, biosurfactants.
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Wheeler 1986), the present study showed that Pseudomonas
spp. can suppress the viability of Verticillium microsclero-
tia in vitro.
Reduction in Verticillium microsclerotia germination
and formation of secondary microsclerotia may result in
a lower Verticillium infection pressure in the field and in
a reduced survival of Verticillium microsclerotia in soil
(Coley-Smith and Cooke 1971). Thus, this study suggests
that Pseudomonas spp. may be promising biological agents
to control Verticillium wilt and they deserve closer atten-
tion in future field studies.
Involvement of biosurfactants and phenazines
It should be noted that the majority of the tested Pseudo-
monas spp. were only effective at high cell densities
(2 · 109 CFU ml)1, see Fig. 2). Based on this finding, we
hypothesized that secondary metabolites, such as phena-
zines and biosurfactants might be involved in their mode
of action, as secondary metabolites are mainly produced
by bacteria at high cell densities (Haas et al. 2000).
Another reason that can be put forward to underpin this
hypothesis is that filter-sterilized culture supernatants of
several of the tested Pseudomonas spp. showed antifungal
activity against Verticillium microsclerotia (Debode et al.
2004).
Two different groups of secondary metabolites were
investigated. A first group of secondary metabolites that
were investigated were the biosurfactants. Biosurfactants
are surface-active compounds capable of affecting the cell
surface of plant pathogenic fungi (Raaijmakers et al.
2006). They can act on lipids and are able to form pores
in the membrane layer (Kim et al. 2004). Given that the
storage compounds present in Verticillium microsclerotia
are lipids (Gordee and Porter 1961), we hypothesized that
biosurfactants may act on these lipids by their permeabi-
lizing activity, resulting in a loss of storage compounds
that are necessary for Verticillium microsclerotia germi-
nation. The present study shows that the biosurfactant
deficient mutants of Pseudomonas CMR12a and Ps.
aeruginosa PNA1 were less effective in the suppression of
the viability of the Verticillium microsclerotia when com-
pared with the wild type, indicating that the former
hypothesis may be supported. In addition, all the wild-
type Pseudomonas strains that were tested in the present
study were effective and they all produce biosurfactants
(data not shown). A third indication that biosurfactants
might be involved in the biological control of the tested
wild-type Pseudomonas strains is that they were all effect-
ive at a cell density of 2 · 109 CFU ml)1 (Fig. 2). This
cell density seems to be necessary to obtain the Critical
Micelle Concentration (CMC) (de Souza J.T. et al.,
personal communication). The CMC is the minimum
amount of surfactants required to cause a decrease in sur-
face tension (de Souza et al. 2003; Raaijmakers et al.
2006). Consequently, this amount of biosurfactants may
be needed to cause a suppressive effect on Verticillium
microsclerotia viability. Finally, it should be noted that
biosurfactant production does not fully account for Verti-
cillium microsclerotia suppression and other mechanisms
are most likely involved in the biological control of
Verticillium microsclerotia. More specifically, the present
study reveals that the biosurfactant mutant of Ps. aerugi-
nosa PNA1 had a residual effect on the formation of sec-
ondary microsclerotia. In addition, the biosurfactant
mutant of Pseudomonas CMR12a had a residual effect
both on Verticillium germination and the formation of
secondary microsclerotia. These residual effects may be
attributed to the production of PCA by those strains (see
below).
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Figure 7 (a) Pseudomonas chlororaphis PCL1391 concentration
2 days after incubation in vicinity of 0 ( ), 5 ( ), 25 ( ),
50 ( ) and 200 ( ) microsclerotia. Detection limit was
100 CFU ml)1. (b) Pseudomonas aeruginosa 7NSK2 concentration
2 days after incubation in vicinity of 0 ( ), 5 ( ), 50 ( ) and
500 ( ) microsclerotia. Detection limit was 100 CFU ml)1.
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A second group of metabolites that were investigated
were the phenazines. Phenazines are able to diffuse across
or insert into the membrane of plant pathogens and act as
a reducing agent, resulting in the generation of superoxide
radicals and hydrogen peroxide (Chin-A-Woeng et al.
2003). The main findings of the present study are that
PCN and pyocyanin are not responsible for the biocontrol
activity of tested Pseudomonas spp., whereas PCA seems to
have a suppressive effect on Verticillium microsclerotia.
PCA is a well-known metabolite involved in the biological
control of several soilborne pathogens by Pseudomonas
spp. (e.g. Mazzola et al. 1995). PCA is the first phenazine
compound formed by those strains, and can be modified
into PCN or pyocyanin by the aid of the phzH or the
phzM gene (Chin-A-Woeng et al. 2001; De Vleesschauwer
et al. 2006). In this study, PCA involvement was demon-
strated by the fact that mutants of Ps. chlororaphis
PCL1391 and Ps. aeruginosa 7NSK2 overproducing PCA
(PCL1121 and 7NSK2-PhzM, respectively) were more
effective in the inhibition of microsclerotia germination
and formation of secondary microsclerotia when com-
pared with the wild-type treatment. In addition, the
biosurfactant mutants of Ps. aeruginosa PNA1 and Pseu-
domonas CMR12a (PNA1-Rl and CMR12a-7Æ97, respect-
ively) both had a residual effect on the formation of
secondary microsclerotia and this may be attributed to the
production of PCA by those two strains. There was no
additional impact of the mutants of Ps. aeruginosa PNA1
and Pseudomonas CMR12a overproducing PCA (PNA1-
PhzH and CMR12a-PhzH, respectively) on the viability of
the Verticillium microsclerotia. This may be attributed to
the fact that the two wild-type strains were already highly
effective in the inhibition of Verticillium microsclerotia
viability and no additional effect of the PCA production
could be obtained. Up to now, we were not able to con-
struct mutants of Ps. aeruginosa PNA1 and Pseudomonas
CMR12a that are completely PCA deficient.
The actual phenazine and biosurfactants concentrations
in the microplate assay have not been measured. These
data would show whether the antagonistic effects were
truly related to the metabolites addressed by the gene
knock-out, and whether effects which only occurred at
109 CFU ml)1 and not at lower concentrations were related
to threshold concentrations of the metabolites produced by
the Pseudomonas spp.
Microsclerotia colonization and competition for
nutrients
Apart from secondary metabolites, a second possible
underlying mechanism that may be involved in the
Pseudomonas-mediated reduction of Verticillium micro-
sclerotia viability is the ability of Pseudomonas spp. to
colonize microsclerotia and utilize nutrients from the
microsclerotia for their own growth. If this is the case,
microsclerotia germination will be most likely inhibited,
as these nutrients are normally used by the microsclerotia
themselves for their germination (Willetts and Bullock
1992). However, it can also be hypothesized that Pseudo-
monas spp. might utilize the nutrients that are released by
the microsclerotia. The release of nutrients by sclerotia in
so-called ‘exudation droplets’ has been suggested to play
an important role in maintaining the physiological
balance within sclerotia (Willetts and Bullock 1992).
Therefore, it can be hypothesized that when Pseudomonas
spp. utilize the nutrients released in the exudation drop-
lets, it follows that the physiological balance of the micro-
sclerotia gets disturbed and the germination of the
microsclerotia is inhibited.
The present study shows that Pseudomonas spp. might
colonize the surface of the microsclerotia, but not the
inner matrix. The adhesion of bacteria on the surface of
the pathogen is an important feature in antagonistic
interactions (Jana et al. 2000) and our results support
that this mechanism may play a role in the biocontrol
activity of the tested Pseudomonas strains. However, the
maximum Pseudomonas carrier capacity of the microscle-
rotia was approx. 5 · 104 CFU ml)1 or approx. 50 Pseu-
domonas colonies per microsclerotium and this bacterial
density is insufficient to kill Verticillium microsclerotia
in vitro (see Fig. 2). Thus, the adhesion of Pseudomonas
spp. on the surface of Verticillium microsclerotia cannot
be the main mechanism involved.
In addition, we also found that the number of Pseudo-
monas bacteria increased when they were in the vicinity
of a sufficient amount of Verticillium microsclerotia. This
result indicates that Pseudomonas spp. might utilize nutri-
ents that are present in the microsclerotia for their
growth. However, the Pseudomonas spp. were only able to
grow until they reached a concentration of approx.
1 · 107 CFU ml)1 (Fig. 7) and this bacterial density is
insufficient to kill the Verticillium microsclerotia in vitro
(Fig. 2). Thus, the growth of Pseudomonas spp. in vicinity
of Verticillium microsclerotia cannot be the main mech-
anism involved in the Pseudomonas-mediated reduction
of Verticillium microsclerotia viability.
Interferences between modes of actions
As until now no single mode of action could be demon-
strated, we believe that there might be interference
between the modes of actions. For example, biosurfac-
tants and phenazines might act synergistically in the
biological control of plant pathogens (Perneel 2006). In
this hypothesis, biosurfactants migrate to the surface of
the microsclerotia and form a thin film. Biosurfactants
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function as such as carrier molecules for phenazines,
enhancing the possibility of encountering the target cell
and concentrating the antibiotics at the place of action
(Perneel 2006). Besides this, the permeabilizing activity of
biosurfactants on the cell wall and membrane can
enhance the efficacy of phenazines by facilitating their
access into the cell (Perneel 2006). Our results support
this hypothesis as all tested wild-type Pseudomonas strains
produce both phenazines and biosurfactants. To further
investigate this hypothesis, mutants that are deficient in
both phenazine- and biosurfactants-production, need to
be constructed and tested for their ability to suppress the
viability of Verticillium microsclerotia.
A second interference may be that the biosurfactants
produced by the Pseudomonas spp. may facilitate the
adhesion of the Pseudomonas spp. on the surface of the
pathogen (Ron and Rosenberg 2001).
Biological relevance and practical implications
This study was carried out under in vitro conditions and
more research is needed to see whether these results can
be extrapolated to field conditions.
First, it needs to be clarified which Pseudomonas densi-
ties can possibly be achieved when Pseudomonas spp. are
incorporated in soil. In this respect, preliminary experi-
ments have been conducted in which the tested Pseudo-
monas strains were incorporated in soil naturally infested
with Verticillium microsclerotia. Results showed that
14 days after incubation, the population density of the
Pseudomonas strains was from 1 · 105 to 1 · 106 CFU g)1
soil (Debode 2005). However, these experiments were
carried out at room temperature (24C) and this is far
above the temperature regime in a field soil. Therefore,
further research is needed to examine what would happen
at lower temperature (16C ⁄ 12C).
Second, it needs to be examined whether the tested
Pseudomonas strains have a significant biocontrol effect
under field conditions, as research in the past has shown
that biocontrol agents are often unsuccessful in field experi-
ments (Mazzola 2004). Preliminary results showed that the
combined incorporation of the tested Pseudomonas spp.
with ryegrass or lignin in soil was more effective in redu-
cing the viability of the Verticillium microsclerotia than the
application of the Pseudomonas spp. alone (Debode 2005).
These results indicate that in field conditions, a combined
treatment may be more successful in controlling Verticil-
lium than the application of Pseudomonas spp. alone.
Conclusions
In summary, this study demonstrates the potential of
some previously described Pseudomonas bacteria as effect-
ive biocontrol agents against Verticillium microsclerotia.
The efficacy of these bacteria when introduced into field
soil (either alone or in combination), is a scope for future
research.
The exact modes of action of the tested Pseudomonas
strains in the suppression of Verticillium microsclerotia
could not be elucidated in the present study. However,
important conclusions can be drawn. First, biosurfac-
tants are the main mechanism involved in the
biological control of Verticillium microsclerotia by Pseu-
domonas CMR12a and Ps. aeruginosa PNA1. Second,
PCA seems to have an inhibitory effect on Verticillium
microsclerotia viability. Third, Pseudomonas spp. can
colonize the microsclerotia surface and utilize nutrients
from the microsclerotia for their growth. Future
research should further explore these modes of action
and possible interferences among them should be stud-
ied.
Acknowledgements
We thank G. Bloemberg for providing bacteria and
mutants. This research was supported by project grants of
the Flemish Institute for the Stimulation of Scientific-
Technological Research in Industry (IWT, Belgium) and
of the Special Research Fund (BOF) of the Ghent Univer-
sity. M. Perneel and J. Pannecoucque were supported by
a specialization fellowship of the Flemish Institute for the
Stimulation of Scientific-Technological Research in Indus-
try (IWT, Belgium).
References
Anjaiah, V., Koedam, N., Nowak-Thompson, B., Loper, J.E.,
Hofte, M., Tambong, J.T. and Cornelis, P. (1998) Involve-
ment of phenazines and anthranilate in the antagonism of
Pseudomonas aeruginosa PNA1 and Tn5 derivatives toward
Fusarium spp. and Pythium spp. Mol Plant Microbe
Interact 11, 847–854.
Bakker, A.W. and Schippers, B. (1987) Microbial cyanide pro-
duction in the rhizosphere in relation to potato yield
reduction and Pseudomonas spp.-mediated plant growth-
stimulation. Soil Biol Biochem 19, 451–457.
Bell, A.A. and Wheeler, M.H. (1986) Biosynthesis and func-
tions of fungal melanins. Annu Rev Phytopathol 24,
411–451.
Berg, G., Fritze, A., Roskot, N. and Smalla, K. (2001) Evalua-
tion of potential biocontrol rhizobacteria, from different
host plants of Verticillium dahliae Kleb. J Appl Microbiol
91, 963–971.
Boyer, H.B. and Roulland-Dossoix, D. (1969) A complemen-
tation analysis of the restriction and modification of
DNA in Escherichia coli. J Mol Biol 4, 459–472.
J. Debode et al. Biological control of Verticillium
ª 2007 The Authors
Journal compilation ª 2007 The Society for Applied Microbiology, Journal of Applied Microbiology 11
Broekaert, W.F., Terras, F.R.G., Cammue, B.P.A. and Vander-
leyden, J. (1990) An automated quantitative assay for
fungal growth inhibition. FEMS Microbiol Lett 69, 55–60.
Buysens, S., Huengens, K., Poppe, J. and Hofte, M. (1996)
Involvement of pyochelin and pyoverdin in suppression
of Pythium-induced damping-off of tomato by Pseudo-
monas aeruginosa 7NSK2. Appl Environ Microbiol 62,
865–871.
Chin-A-Woeng, T.F.C., Bloemberg, G.V., van der Bij, A.J., van
der Drift, K.M.G.F., Schripsema, J., Kroon, B., Scheffer,
R.J., Keel, C. et al. (1998) Biocontrol by phenazine-1-car-
boxamide-producing Pseudomonas chlororaphis PCL1391 of
tomato root rot caused by Fusarium oxysporum f. sp. radicis-
lycopersici.Mol Plant Microbe Interact 11, 1069–1077.
Chin-A-Woeng, T.F.C., Thomas-Oates, J.E., Lugtenberg, B.J.J.
and Bloemberg, G.V. (2001) Introduction of the phzH
gene of Pseudomonas chlororaphis PCL1391 extends the
range of biocontrol ability of phenazine-1-carboxylic acid-
producing Pseudomonas spp. strains. Mol Plant Microbe
Interact 14, 1006–1015.
Chin-A-Woeng, T.F.C., Bloemberg, G.V. and Lugtenberg, B.J.J.
(2003) Phenazines and their role in biocontrol by Pseudo-
monas bacteria. New Phytol 157, 503–523.
Coley-Smith, J.R. and Cooke, R.C. (1971) Survival and germi-
nation of fungal sclerotia. Annu Rev Phytopathol 9, 65–92.
De Vleesschauwer, D., Cornelis, P. and Hofte, M. (2006)
Redox-active pyocyanin secreted by Pseudomonas aerugi-
nosa 7NSK2 triggers systemic resistance to Magnaporthe
grisea but enhances Rhizoctonia solani susceptibility in rice.
Mol Plant Microbe Interact 19, 1406–1419.
Debode, J. (2005) Integrated control of Verticillium wilt of
cauliflower. PhD Thesis, Ghent University, Ghent, Belgium.
Debode, J., Claeys, D. and Hofte, M. (2004) Control of Verti-
cillium wilt of cauliflower with crop residues, lignin and
microbial antagonists. IOBC WPRS Bull 27, 41–45.
Debode, J., Clewes, E., De Backer, G. and Hofte, M. (2005)
Lignin is involved in the reduction of Verticillium dahliae
var. longisporum inoculum in soil by crop residue incor-
poration. Soil Biol Biochem 37, 301–309.
Denef, V.J., Klappenbach, J.A., Patrauchan, M.A., Florizone,
C., Rodrigues, J.L.M., Tsoi, T.V., Verstraete, W., Eltis, L.D.
et al. (2006) Genetic and genomic insights into the role of
benzoate-catabolic pathway redundancy in Burkholderia
xenovorans LB400. Appl Environ Microbiol 72, 585–595.
Dwivedi, D. and Johri, B.N. (2003) Antifungals from fluores-
cent pseudomonads: biosynthesis and regulation. Curr Sci
India 85, 1693–1703.
Ellis, R.J., Timms-Wilson, T.M., Beringer, J.E., Rhodes, D.,
Renwick, A., Stevenson, L. and Bailey, M.J. (1999) Ecologi-
cal basis for biocontrol of damping-off disease by Pseudo-
monas fluorescens 54 ⁄ 96. J Appl Microbiol 87, 454–463.
Fahima, T., Madi, J. and Henis, Y. (1992) Ultrastructure and
germinability of Verticillium dahliae microsclerotia parasi-
tized by Talaromyces flavus on agar medium and in treated
soil. Biocontrol Sci Technol 2, 69–78.
Figurski, D.H. and Helinski, D.R. (1979) Replication of an ori-
gin-containing derivative of plasmid function provided in
trans. Proc Natl Acad Sci USA 76, 1648–1652.
Frank, L.H. and Demoss, R.D. (1959) On the biosynthesis of
pyocyanin. J Bacteriol 77, 776–782.
Fravel, D.R., Kim, K.K. and Papavizas, G.C. (1987) Viability of
microsclerotia of Verticillium dahliae reduced by a metabo-
lite produced by Talaromyces flavus. Phytopathology 77,
616–619.
Gordee, R.S. and Porter, C.L. (1961) Structure, germination
and physiology of microsclerotia of Verticillium albo-
atrum. Mycologia 53, 171–182.
Haas, D., Blumer, C. and Keel, C. (2000) Biocontrol ability of
fluorescent pseudomonads genetically dissected: import-
ance of positive feedback regulation. Curr Opin Biotechnol
11, 290–297.
Hanahan, D. (1983) Studies on transformation of Escherichia
coli with plasmids. J Mol Biol 166, 557–580.
Hawke, M.A. and Lazarovits, G. (1994) Production and mani-
pulation of individual microsclerotia of Verticillium dahliae
for use in studies of survival. Phytopathology 84, 883–890.
Iswandi, A., Bossier, P., Vandenabeele, J. and Verstraete, W.
(1987) Effect of seed inoculation with the rhizopseudo-
monas strain 7NSK2 on the root microbiota of maize (Zea
mays) and barley (Hordeum vulgare). Biol Fertil Soils 3,
153–158.
Jain, D.K., Thomson, D.K., Lee, H. and Trevors, J.T. (1991)
A drop-collapsing technique test for screening surfactant
producing microorganisms. J Microbiol Methods 13, 271–
279.
Jana, T.K., Srivastva, A.K., Csery, K. and Arora, D.K. (2000)
Agglutination potential of Pseudomonas fluorescens in rela-
tion to energy stress and colonization of Macrophomina
phaseolina. Soil Biol Biochem 32, 511–519.
Kim, K.K., Fravel, D.R. and Papavizas, G.C. (1988) Identifica-
tion of a metabolite produced by Talaromyces flavus as
glucose-oxidase and its role in the biocontrol of Verticil-
lium dahliae. Phytopathology 78, 488–492.
Kim, P.I., Bai, H., Bai, D., Chae, H., Chung, S., Kim, Y., Park,
R. and Chi, Y.T. (2004) Purification and characterization
of a lipopeptide produced by Bacillus thuringiensis CMB26.
J Appl Microbiol 97, 942–949.
King, E.O., Ward, M.K. and Raney, D.E. (1954) Two simple
media for demonstration of pyocyanin and fluorescin.
J Lab Clin Med 44, 301–307.
Kinscherf, T.G. and Willis, D.K. (1999) Swarming by Pseudo-
monas syringae B728a Requires gacS (lemA) and gacA but
not the acyl-homoserine lacotne biosynthetic gene ahlI.
J Bacteriol 181, 4133–4136.
Leben, S.D., Wadi, J.A. and Easton, G.D. (1987) Effects of
Pseudomonas fluorescens on potato plant growth and con-
trol of Verticillium dahliae. Phytopathology 77, 1592–1595.
Marx, C.J. and Lidstrom, M.E. (2002) Broad-host-range cre-
lox system for antibiotic marker recycling in Gram-negat-
ive bacteria. Biotechniques 33, 1062–1067.
Biological control of Verticillium J. Debode et al.
12 Journal compilation ª 2007 The Society for Applied Microbiology, Journal of Applied Microbiology
ª 2007 The Authors
Mavrodi, D.V., Bonsall, R.F., Delaney, S.M., Soule, M.J., Phil-
lips, G. and Thomashow, L.S. (2001) Functional analysis
of genes for biosynthesis of pyocyanin and phenazine-1-
carboxamide from Pseudomonas aeruginosa PAO1. J Bacte-
riol 183, 6454–6465.
Mazzola, M. (2004) Assessment and management of soil
microbial community structure for disease suppression.
Annu Rev Phytopathol 42, 35–59.
Mazzola, M., Fujimoto, D.K., Thomashow, L.S. and Cook, R.J.
(1995) Variation in sensitivity of Gaeumannomyces gra-
minis to antibiotics produced by fluorescent Pseudomonas
spp. and effect on biological control of take-all of wheat.
Appl Environ Microbiol 61, 2554–2559.
Melouk, H.A. (1992) Verticillium. In Methods for Research on
Soilborne Phytopathogenic Fungi ed. Singleton, L.L., Mihail,
J.D. and Rush, C.M. pp. 175–177. St Paul, MN, USA: APS
Press.
Mercado-Blanco, J., Rodriguez-Jurado, D., Hervas, A. and
Jimenez-Diaz, R.M. (2004) Suppression of Verticillium wilt
in olive planting stocks by root-associated fluorescent
Pseudomonas spp. Biol Control 30, 474–486.
Pegg, G.F. and Brady, B.L. (2002) Verticillium Wilts. Walling-
ford, UK: CABI publishing.
Perneel, M. (2006) The root rot pathogen Pythium myriotylum
on cocoyam (Xanthosoma sagittifolium): intraspecific vari-
ability and biological control. PhD Thesis, Ghent Univer-
sity, Ghent, Belgium.
Raaijmakers, J.M., de Bruijn, I. and de Kock, M.J.D. (2006)
Cyclic lipopeptide production by plant-associated Pseudo-
monas species: diversity, activity, biosynthesis and regula-
tion. Mol Plant Microbe Interact 19, 699–710.
Ron, E.Z. and Rosenberg, E. (2001) Natural roles of biosurfac-
tants. Environ Microbiol 3, 229–236.
Sacherer, P., Defago, G. and Haas, D. (1994) Extracellular pro-
tease and phospholipase-C are controlled by the global
regulatory gene gacA in the biocontrol strain Pseudomonas
fluorescens CHA0. FEMS Microbiol Lett, 116, 155–160.
Sambrook, J., Fritsch, E.F. and Maniatis, T.A. (1989) Molecular
Cloning: A Laboratory Manual, 2nd edn. Cold Spring
Harbor, NY: Cold Spring Harbor Laboratory press.
Schnathorst, W.C. (1981) Life cycle and epidemiology of Verti-
cillium. In Fungal Wilt Diseases of Plants ed. Mace, M.E.,
Bell, A.A. and Beckman, C.H. pp. 81–111. New York:
Academic Press.
de Souza, J.T., de Boer, M., de Waard, P., van Beek, T.A. and
Raaijmakers, J.M. (2003) Biochemical, genetic, and zoo-
sporicidal properties of cyclic lipopeptide surfactants pro-
duced by Pseudomonas fluorescens. Appl Environ Microbiol
69, 7161–7172.
Stanghellini, M.E. and Miller, R.M. (1997) Biosurfactants: their
identity and potential efficacy in the biological control of
zoosporic plant pathogens. Plant Dis 81, 4–12.
Tambong, J.T. and Ho¨fte, M. (2001) Phenazines are involved in
biocontrol of Pythium myriotylum on cocoyam by Pseudo-
monas aeruginosa PNA1. Eur J Plant Pathol 107, 511–521.
Thomashow, L.S. and Weller, D.M. (1988) Role of a phenazine
antibiotic from Pseudomonas fluorescens in biological con-
trol of Gaeumannomyces graminis var. tritici. J Bacteriol
170, 3499–3508.
Tjamos, E.C. (2000) Strategies in developing methods and
applying techniques for the biological control of Verticil-
lium dahliae – short review. In Advances in Verticillium
Research and Disease Management. ed. Tjamos, E.C., Rowe,
R.C., Heale, J.B. and Fravel, D.R. pp. 227–231. St Paul,
MN, USA: APS Press.
Velazhahan, R., Samiyappan, R. and Vidhyasekaran, P. (1999)
Relationship between antagonistic activities of Pseudomon-
as fluorescens isolates against Rhizoctonia solani and their
production of lytic enzymes. J Plant Dis Prot 106, 244–250.
Willetts, H.J. and Bullock, S. (1992) Developmental biology
and sclerotia. Mycol Res 96, 801–816.
Windgassen, M., Urban, A. and Jaeger, K.E. (2000) Rapid gene
inactivation in Pseudomonas aeruginosa. FEMS Microbiol
Lett 193, 201–205.
J. Debode et al. Biological control of Verticillium
ª 2007 The Authors
Journal compilation ª 2007 The Society for Applied Microbiology, Journal of Applied Microbiology 13
